PR Newswire Clinical TrialsOriginal article
MOYOM Advances European Regenerative Aesthetics Through APHRANEL® EU MDR Certification and Strategic Scientific Collaboration with Expert2Expert
RegulatoryapprovedAPHRANEL®Positive
AI Analysis
Summary
MOYOM announced EU MDR certification for APHRANEL® and established a strategic scientific collaboration with Expert2Expert to advance its European regenerative aesthetics strategy.
Outcome Details
EU MDR certification achieved
Importance:6/10
Sentiment:
0.70
EU MDR certificationmedical deviceregenerative aestheticsEuropean expansionstrategic partnership
Related Companies
Read the original article
Published by PR Newswire Clinical Trials on July 31, 2026 9:17 AM